Frontlight ResearchEarly access
Gaucher disease trials in Saudi Arabia
1 of 2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in Saudi ArabiaA Gaucher Disease Gene Therapy Trial With FLT201
- Where
- Riyadh
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Spur Therapeutics
See details and how to joinNCT07223944 · EU 2025-520765-50-00